Find a Doctor

George Fountzilas
GF
Areas of Expertise

George Fountzilas

Aristotle University Of Thessaloniki
Male

Bio

George Fountzilas is in Thessaloniki, Greece. They have been an author on 372 peer reviewed articles and participated in 3 clinical trials in the past 15 years.

Areas of Expertise

Contact

Thessaloniki, ESYE12, GR

Latest Research

Latest Advance
Study
  • Condition: Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer (MBC)
  • Journal: British journal of cancer
  • Treatment Used: Cabaziitaxel
  • Number of Patients: 84
  • Published —
This study evaluated the effectiveness and safety of cabazitaxel as second-line treatment (treatment after the initial treatment has failed, stopped working, or has side effects that aren't tolerated) for patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) previously treated with taxanes.
Latest Advance
Study
  • Condition: Colon cancer
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Bevacizumab
  • Number of Patients: 2867
  • Published —
The study researched the effects of Bevacizumab in addition to their treatment for colon cancer.
Latest Advance
Study
  • Condition: Locally Advanced or Metastatic Pancreatic Cancer
  • Journal: Targeted oncology
  • Treatment Used: Gemcitabine Combined with the mTOR Inhibitor Temsirolimus
  • Number of Patients: 30
  • Published —
The study aimed to determine the effects of various doses of Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in treating locally advanced or metastatic pancreatic cancer.
Latest Advance
Study
  • Condition: Renal-cell carcinoma
  • Journal: International journal of clinical oncology
  • Treatment Used: Bevacizumab/temsirolimus
  • Number of Patients: 39
  • Published —
This study evaluated the combination of bevacizumab with temsirolimus in patients with advanced renal-cell carcinoma relapsing after first-line treatment.
Latest Advance
Study
  • Condition: Glioblastoma
  • Journal: The oncologist
  • Treatment Used: Bevacizumab
  • Number of Patients: 123
  • Published —
In this study, researchers evaluated the safety and effectiveness of staying on bevacizumab through multiple treatments for patients with relapsed glioblastoma who had progressed after first-line treatment with radiotherapy, temozolomide, and bevacizumab.
Latest Advance
Study
  • Condition: Metastatic Colorectal Cancer (mCRC)
  • Journal: Clinical colorectal cancer
  • Treatment Used: Leucovorin, 5-Fluorouracil, Irinotecan, and Oxaliplatin (FOLFIRI) plus Aflibercept
  • Number of Patients: 73
  • Published —
This trial studied the effectiveness and safety of leucovorin, 5-fluorouracil, irinotecan, and oxaliplatin (FOLFIRI) combined with aflibercept as first-line treatment for patients with metastatic colorectal cancer (mCRC).

Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 600
  • Start Date: November 21, 2019
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug, Biological
  • Participants: 470
  • Start Date: July 18, 2019
A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: January 29, 2019
Phase Ib-II Study of Ramucirumab Combined With Standard Nab-paclitaxel and Gemcitabine as First-line Treatment in Patients With Advanced Pancreatic Adenocarcinoma

All Publications
View All

Publication
Study
  • Journal: Data in brief
  • Published —
Genotyping data of routinely processed matched primary/metastatic tumor samples.
Publication
Study
  • Journal: Human pathology
  • Published —
Genotype-phenotype associations in colorectal adenocarcinomas and their matched metastases.

Contact

Thessaloniki, ESYE12, GR

Insurance

Contact them to find out if they accept your insurance plan.